Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.84 USD
-0.03 (-0.23%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $12.86 +0.02 (0.16%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth B Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CCRN 12.84 -0.03(-0.23%)
Will CCRN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
Kforce (KFRC) Lags Q2 Earnings Estimates
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for CCRN
Cross Country Healthcare (CCRN) Shares Climb Amid Acquisition Review Update
Cross Country Healthcare gains on report it likely won't be subject of FTC meeting
Cross Country Healthcare (CCRN) Shares Drop Amid FTC Meeting Concerns
Cross Country Healthcare drops amid news of FTC meeting next week
Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade)